# FDA Inspection 1122150 - Michelle D. Welch, M.D. - February 14, 2020

Source: https://www.keypedia.com/records/fda_inspections/michelle-d-welch-md/7b2fd623-e805-42f3-a6cd-4647f4a78daa
Source feed: FDA_Inspections

> FDA Inspection 1122150 for Michelle D. Welch, M.D. on February 14, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1122150
- Company Name: Michelle D. Welch, M.D.
- Inspection Date: 2020-02-14
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1299146 - 2026-01-15](https://www.keypedia.com/records/fda_inspections/michelle-d-welch-md/f49c24b0-cebd-4534-91fb-3f7f88fc37d7)
- [FDA Inspection 1299146 - 2026-01-15](https://www.keypedia.com/records/fda_inspections/michelle-d-welch-md/18ac66e6-7f69-4c3f-944f-1e8db248a11c)
- [FDA Inspection 1287794 - 2025-09-12](https://www.keypedia.com/records/fda_inspections/michelle-d-welch-md/6c5ee345-1b97-41af-bfca-30b9a0ea3581)
- [FDA Inspection 1287794 - 2025-09-12](https://www.keypedia.com/records/fda_inspections/michelle-d-welch-md/3dd3cd02-256b-4f36-94a7-359efc6602d0)

Company: https://www.keypedia.com/companies/michelle-d-welch-md/ee4fc220-bef6-480a-b399-29123d78f56f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c